SFFS
IPCI

Stonehage Fleming Financial Services’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Stonehage Fleming Financial Services’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-206
Closed -$170K – 310
2016
Q1 		$170K Buy
+206
New +$4.58K 0.01% 225

Other funds holding IPCI

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Stonehage Fleming Financial Services's IPCI Position: Q2 2016 in Review

Stonehage Fleming Financial Services sold out of Intellipharmaceuticals International Inc. (IPCI) in Q2 2016, closing a stake of 206 shares — an estimated $170K sold.

Stonehage Fleming Financial Services first reported a position in IPCI in Q1 2016 and held it in 1 quarter. The position peaked at $170K in Q1 2016. 18 funds tracked by Wall St. Rank hold IPCI as of Q2 2016.

  • Stonehage Fleming Financial Services reported no remaining Intellipharmaceuticals International Inc. position as of Q2 2016 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 206 Intellipharmaceuticals International Inc. shares in Q2 2016, an estimated $170K.
  • Stonehage Fleming Financial Services first reported a position in Intellipharmaceuticals International Inc. in Q1 2016 and held it in 1 quarter.
  • Stonehage Fleming Financial Services's Intellipharmaceuticals International Inc. position peaked at $170K in Q1 2016.
  • 18 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q2 2016.

Based on Stonehage Fleming Financial Services's 13F filing for Q2 2016, filed 11 Oct 2019.